Lotus Ventures Inc (CSE:J) has appointed David Hyde of David Hyde & Associates as an adviser to the company. In addition, David will continue in his role as consultant on the company’s late stage license application before Health Canada. We are delighted to have David remain involved in our exciting future, as he has been instrumental in assisting us to our late-stage status with a Confirmation of Readiness.
About Lotus Ventures
Lotus Ventures Inc. (“Lotus” or the “Company”) has achieved a major milestone with the receipt from Health Canada of the Confirmation of Readiness for a License Under the Access to Cannabis for Medical Purposes Regulations (ACMPR). This represents acceptance of our detailed application. Lotus’ construction of its 22,500-square foot purpose-built indoor growing facility in Armstrong, B.C. is in full force and will be completed in August 2018. The company has sufficient capital to finish the construction of the facility, and to exercise its option to acquire the 23 acre Armstrong property in June 2018. The next milestone is receipt of the Cultivation Licence which will allow Lotus to begin growing cannabis. This will be granted once construction is finished and then a “Sale License” will be issued after the first two crops have been grown successfully.
About David Hyde & Associates
David Hyde & Associates is a full-service cannabis security & licensing advisory service based in Toronto & operating internationally. The firm offers security & strategic licensing advisory services based upon a defensible framework of applicable laws, regulatory standards and industry best practice. The 13-member David Hyde & Associates team has extensive experience consulting within the regulated cannabis sector in Canada & beyond & is proud to have been the first Associate Member of the Cannabis Canada Association.
About David Hyde
David Hyde, M.Sc. CPC is one of Canada’s top independent security consultants. He’s an industry-recognized leader & trusted senior advisor to many large organizations. Over a 32-year career, David has operated an award-winning business, secured some of Canada’s most iconic landmarks & led the security program for a $19 billion global corporation with 60 million sq. ft. of facility assets. He is one of only 4 Canadians to be accepted as a member of the world-renowned International Association of Professional Security Consultants (IAPSC).
David holds a M.Sc. (w/Distinction) in Security & Risk Management from the University of Leicester and Certificate in Security Management from the University of Calgary. He completed The Wharton School Development Program for Security Executives and is a Certified Advanced Level Crime Prevention (CPTED) Practitioner. David is a sought- after writer, speaker & thought leader within Canada’s cannabis industry. He is the only Canadian member on the Security Committee for the Foundation of Cannabis Unified Standards.
Over the past 5 years, David and his team have worked on over 290 licensed producer (LP) and licensed dealer (LD) applications under the MMPR/ACMPR/NCR, including 57 of the 104 currently-licensed LPs.
ON BEHALF OF THE BOARD Lotus Ventures Inc. “Dale McClanaghan” Dale McClanaghan, President and CEO
For further information: Dale McClanaghan: email@example.com (604) 644-9844 or Daniel McRobert, Communications firstname.lastname@example.org (604) 842-4625
Meanwhile, two longstanding cannabis partners ended their relationship.
Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development
Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.
The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 with Planned Completion and Emergency Use Authorization Request
Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.
With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.
HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.
DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.